Chargement en cours...
Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence
Background: Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor combination that mainly targets Gram-negative bacteria. The current international guidelines recommend including C/T treatment in the empirical therapy for hospital-acquired pneumonia (HAP) and ventilator-associated pneumon...
Enregistré dans:
| Publié dans: | Life (Basel) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8225018/ https://ncbi.nlm.nih.gov/pubmed/34073847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11060474 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|